Real-time enrollment status for this biliary tract cancer clinical trial
Current Status
Recruiting
Checked: July 16, 2026 at 10:26 PM UTC
| NCT Number | NCT06282575 |
| Recruiting Status | Recruiting |
| Condition | Biliary Tract Cancer |
| Phase | PHASE3 |
| Target Enrollment | 286 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Jazz Pharmaceuticals |
| Last Updated on CT.gov | July 14, 2026 (2 days ago) |
As of July 16, 2026: Clinical trial NCT06282575 is currently recruiting participants. This phase3 study for biliary tract cancer is actively seeking new participants at 21 locations across the United States. The study is sponsored by Jazz Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06282575 is actively recruiting participants as of July 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06282575 was last updated 2 days ago (July 14, 2026). HelloStudys verifies this status automatically.